Dr. Charles D Bengtson, M.D.
Claim this profileUniversity of Kansas Medical Center
Studies Cystic Fibrosis Liver Disease
Studies Thyroid Fibrosis
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Charles D Bengtson, M.D. is currently running
Metformin
for Cystic Fibrosis
The purpose of this study is to assess the efficacy of metformin to improve airway ion channel function in those with CF-related diabetes (CFRD)
Recruiting1 award Phase 23 criteria
Lung Transplant Education
for Cystic Fibrosis
Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF and low lung function die each year than undergo lung transplant. More than half of people with CF who die without a lung transplant were never referred for consideration. Patient preference not to undergo lung transplant may account for 25-40% of decisions to defer referral. Rates of death without transplant are higher for people with CF who are members of marginalized communities, including those with Black race, Hispanic ethnicity, or low socioeconomic status. Increasing awareness of lung transplant among people with CF, and promoting understanding of the risks and benefits of transplant, can potentially reduce the number of people with CF who die without a lung transplant. The CF Foundation (CFF) lung transplant referral guidelines were developed to optimize the timing of referral for lung transplant. These guidelines recommend annual conversations with people with CF once their forced expiratory volume in one second (FEV1) is \<50% predicted. Considering lung transplant as a treatment option before it is medically needed will allow more time to learn about lung transplant and address any barriers to lung transplant that may exist. Investigators are interested in understanding how people with CF use lung transplant educational resources and how one prepares for having discussions and/or making decisions about lung transplant as a treatment option for advanced CF. The purpose of this study is to test whether a research website improves patient preparedness for discussions about lung transplant. Investigators also aim to understand whether there are unique factors that affect people with CF from communities with decreased access to transplant ("communities of concern"). Study involvement will span 6 months and study activities will involve the following: * Four Zoom research sessions (15-30 minutes each) * Survey assessments * Access to a research website that contains educational resources about lung transplant * Audio recording of a routine CF clinic visit to determine if and how lung transplant is discussed between a participant and his/her/their CF doctor
Recruiting1 award N/A2 criteria
More about Charles D Bengtson, M.D.
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Charles D Bengtson, M.D. has experience with
- Losartan
- Metformin Hydrochloride
- Investigator-designed Lung Transplant Education Resource
- Publicly Available Transplant Education Resource
Breakdown of trials Charles D Bengtson, M.D. has run
Cystic Fibrosis Liver Disease
Thyroid Fibrosis
Cystic Fibrosis
Pneumonia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles D Bengtson, M.D. specialize in?
Charles D Bengtson, M.D. focuses on Cystic Fibrosis Liver Disease and Thyroid Fibrosis. In particular, much of their work with Cystic Fibrosis Liver Disease has involved treating patients, or patients who are undergoing treatment.
Is Charles D Bengtson, M.D. currently recruiting for clinical trials?
Yes, Charles D Bengtson, M.D. is currently recruiting for 3 clinical trials in Kansas City Kansas. If you're interested in participating, you should apply.
Are there any treatments that Charles D Bengtson, M.D. has studied deeply?
Yes, Charles D Bengtson, M.D. has studied treatments such as Losartan, Metformin Hydrochloride, Investigator-designed lung transplant education resource.
What is the best way to schedule an appointment with Charles D Bengtson, M.D.?
Apply for one of the trials that Charles D Bengtson, M.D. is conducting.
What is the office address of Charles D Bengtson, M.D.?
The office of Charles D Bengtson, M.D. is located at: University of Kansas Medical Center, Kansas City, Kansas 66160 United States. This is the address for their practice at the University of Kansas Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.